Elanco Animal Health Incorporated
ELAN
$17.82
-$0.145-0.81%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -83.58% | 937.50% | -102.20% | 828.00% | -256.25% |
Total Depreciation and Amortization | 5.92% | 22.58% | -27.06% | 11.84% | -2.56% |
Total Amortization of Deferred Charges | -11.11% | -77.50% | -- | -- | 0.00% |
Total Other Non-Cash Items | 0.00% | 114.29% | 94.35% | -1,039.39% | 447.37% |
Change in Net Operating Assets | 121.94% | -523.21% | -77.42% | 1,027.27% | 112.43% |
Cash from Operations | 6,025.00% | -102.26% | 9.26% | -19.00% | 9,900.00% |
Capital Expenditure | 12.31% | -38.30% | -11.90% | -23.53% | -41.67% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -100.00% | -- | -100.00% | -- | -100.00% |
Other Investing Activities | 150.00% | 71.43% | 12.50% | -900.00% | 120.00% |
Cash from Investing | 3.45% | 35.56% | -107.23% | 3,869.70% | -189.19% |
Total Debt Issued | -100.00% | -- | -100.00% | 191.67% | 20.00% |
Total Debt Repaid | -150.56% | -368.42% | 97.74% | -693.40% | -87.61% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 1,550.00% | -433.33% | 175.00% | -700.00% | 92.86% |
Cash from Financing | -400.00% | 262.50% | 97.61% | -1,340.86% | -244.44% |
Foreign Exchange rate Adjustments | -6.90% | 137.66% | -1,062.50% | 366.67% | 84.21% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 173.68% | 186.36% | -129.73% | 4.23% | 1,114.29% |